We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
(Approval lapsed) ZYPADHERA olanzapine 210mg powder and solvent for prolonged release suspension for injection (Germany)
Section 19A approved medicine
(Approval lapsed) ZYPADHERA olanzapine 210mg powder and solvent for prolonged release suspension for injection (Germany)
Section 19A approval holder
Link Medical Products Pty Ltd ABN 73 010 971 516
Phone
1800 181 060
Approved until
Status
Expired
Medicines in short supply/unavailable
ZYPREXA RELPREVV olanzapine (as pamoate monohydrate) 210mg powder for injection vial with diluent vial - ARTG 143658
Indication(s)
It is a long-acting injectable formulation of olanzapine indicated for maintenance treatment of schizophrenia in adult patients sufficiently stabilised during acute treatment with oral olanzapine.
Additional information
As Link Healthcare are sourcing this product from multiple German distributors, there may be slight variances in the packaging that appears below.
Images
